Citadel Advisors’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $115K | Buy |
|
|||||
|
2024
Q4 | $6.96K | Buy |
|
|||||
|
2024
Q3 | – | Hold |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $449K | Buy |
|
|||||
|
2023
Q4 | $36.1K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $101K | Sell |
|
|||||
|
2023
Q1 | $149K | Buy |
|
|||||
|
2022
Q4 | $70.7K | Buy |
|
|||||
|
2022
Q3 | – | Hold |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $120K | Sell |
|
|||||
|
2021
Q4 | $252K | Sell |
|
|||||
|
2021
Q3 | $326K | Buy |
|
|||||
|
2021
Q2 | $141K | Sell |
|
|||||
|
2021
Q1 | $329K | Buy |
|
|||||
|
2020
Q4 | $180K | Sell |
|
|||||
|
2020
Q3 | $579K | Buy |
|
|||||
|
2020
Q2 | $163K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $158K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $82K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $204K | Buy |
|